Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:01:56.564Z.
Calculation as of: 2026-10-06T18:01:56.564Z.
Quote observation: 2026-10-06T18:00:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
DarioHealth Corp.
Market Cap
$43.88M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.59M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.38M
Operating Cash Flow Yield
12.04%
TTM Avg
4.34%
3Y Avg
2.96%
5Y Avg
2.96%
Market Cap
$43.22M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$45.20M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.92M
Operating Cash Flow Yield
2.62%
TTM Avg
2.14%
3Y Avg
3.12%
5Y Avg
3.12%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $43.88M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.92M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.59M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.38M | 12.04% | 4.34% | 2.96% | 2.96% |
| CVRx, Inc. (CVRX)vs › | $44.45M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.22M | N/A | 11.87% | 9.02% | 6.85% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $41.92M | 2.62% | 2.14% | 3.12% | 3.12% |
| Veru Inc. (VERU)vs › | $41.09M | N/A | 0.02% | 0.02% | 0.25% |
| Instil Bio, Inc. (TIL)vs › | $47.27M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
